Search

Your search keyword '"Khan, Na"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Khan, Na" Remove constraint Author: "Khan, Na" Publisher academic press Remove constraint Publisher: academic press
52 results on '"Khan, Na"'

Search Results

1. Anti-Acanthamoebic effects of silver-conjugated tetrazole nanoparticle.

2. Deregulated transcription factors in the emerging cancer hallmarks.

3. Exploring nutrient removal mechanisms in column-type SBR with simultaneous nitrification and denitrification.

4. Experimental investigation of H 3 PO 4 activated papaya peels for methylene blue dye removal from aqueous solution: Evaluation on optimization, kinetics, isotherm, thermodynamics, and reusability studies.

5. Characterization of municipal solid waste: Measures towards management strategies using statistical analysis.

6. Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics.

7. Is fat taste associated with diet quality? A cross-sectional study conducted among Tunisian adults.

8. A novel montmorillonite clay-cetylpyridinium chloride complex as a potential antiamoebic composite material in contact lenses disinfection.

9. Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options.

10. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.

11. Horizontal sub surface flow Constructed Wetlands coupled with tubesettler for hospital wastewater treatment.

12. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.

14. Production of a monoclonal antibody against a mannose-binding protein of Acanthamoeba culbertsoni and its localization.

15. Strategies to counter transmission of "superbugs" by targeting free-living amoebae.

16. Crocodiles and alligators: Antiamoebic and antitumor compounds of crocodiles.

17. Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens.

18. Acanthamoeba castellanii interactions with Streptococcus pneumoniae and Streptococcus pyogenes.

19. Pathogenesis of microbial keratitis.

20. The effect of peptidic and non-peptidic proteasome inhibitors on the biological properties of Acanthamoeba castellanii belonging to the T4 genotype.

21. Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype.

22. Isolation of Balamuthia mandrillaris-specific antibody fragments from a bacteriophage antibody display library.

23. The role of genomic islands in Escherichia coli K1 interactions with intestinal and kidney epithelial cells.

24. A proposed cascade of vascular events leading to granulomatous amoebic encephalitis.

25. Anaerobic respiration: In vitro efficacy of Nitazoxanide against mitochondriate Acanthamoeba castellanii of the T4 genotype.

26. The relation of saturated fats and dietary cholesterol to childhood cognitive flexibility.

27. The role of G protein coupled receptor-mediated signaling in the biological properties of Acanthamoeba castellanii of the T4 genotype.

28. In vitro inhibition of protease-activated receptors 1, 2 and 4 demonstrates that these receptors are not involved in an Acanthamoeba castellanii keratitis isolate-mediated disruption of the human brain microvascular endothelial cells.

29. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.

30. Inefficacy of marketed contact lens disinfection solutions against keratitis-causing Acanthamoeba castellanii belonging to the T4 genotype.

31. The effect of different environmental conditions on the encystation of Acanthamoeba castellanii belonging to the T4 genotype.

32. Anti-Acanthamoebic properties of resveratrol and demethoxycurcumin.

33. Staphylococcus aureus exhibit similarities in their interactions with Acanthamoeba and ThP1 macrophage-like cells.

34. Escherichia coli K1-induced cytopathogenicity of human brain microvascular endothelial cells.

35. Acanthamoeba interactions with the blood-brain barrier under dynamic fluid flow.

36. AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS.

37. War of the microbial worlds: who is the beneficiary in Acanthamoeba-bacterial interactions?

38. Acanthamoeba is an evolutionary ancestor of macrophages: a myth or reality?

39. Is Acanthamoeba pathogenicity associated with intracellular bacteria?

40. The type III secretion system is involved in Escherichia coli K1 interactions with Acanthamoeba.

41. Novel in vitro and in vivo models to study central nervous system infections due to Acanthamoeba spp.

42. Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets.

43. Carbohydrate analysis of Acanthamoeba castellanii.

44. Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations.

45. Balamuthia amoebic encephalitis: an emerging disease with fatal consequences.

46. N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia.

47. Ecto-ATPases of clinical and non-clinical isolates of Acanthamoeba.

48. Acanthamoeba interactions with human brain microvascular endothelial cells.

49. Outer membrane protein A and cytotoxic necrotizing factor-1 use diverse signaling mechanisms for Escherichia coli K1 invasion of human brain microvascular endothelial cells.

50. Pathogenesis of Acanthamoeba infections.

Catalog

Books, media, physical & digital resources